MARKET

CHE

CHE

Chemed
NYSE

Real-time Quotes | Nasdaq Last Sale

445.21
-1.14
-0.26%
After Hours: 445.21 0 0.00% 17:27 02/26 EST
OPEN
448.80
PREV CLOSE
446.35
HIGH
451.76
LOW
437.75
VOLUME
177.87K
TURNOVER
--
52 WEEK HIGH
560.00
52 WEEK LOW
330.01
MARKET CAP
7.10B
P/E (TTM)
22.84
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
10-K: CHEMED CORP
Edgar Online - (EDG = 10Q, 10K) · 1d ago
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Teladoc (TDOC) and LHC Group (LHCG)
SmarterAnalyst · 2d ago
DJ Chemed Price Target Cut to $580.00/Share From $600.00 by Oppenheimer
Dow Jones · 2d ago
DJ Chemed Is Maintained at Outperform by Oppenheimer
Dow Jones · 2d ago
--Analyst Actions: Oppenheimer Adjusts Chemed PT to $580 From $600, Maintains Outperform Rating
MT Newswires · 3d ago
DJ Chemed's CEO Kevin McNamara on Q4 2020 Results -- Earnings Call Transcript >CHE
Dow Jones · 3d ago
Chemed (CHE) Q4 Earnings Miss Estimates, 2021 Outlook Dull
Zacks.com · 3d ago
Global Death Care Service Market Size by End users, Service Type: Covid 19 Impact Outlook and Forecast-2026
The Express Wire · 3d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CHE. Analyze the recent business situations of Chemed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CHE stock price target is 595.00 with a high estimate of 605.00 and a low estimate of 580.00.
EPS
Institutional Holdings
Institutions: 648
Institutional Holdings: 15.82M
% Owned: 99.17%
Shares Outstanding: 15.95M
TypeInstitutionsShares
Increased
163
914.02K
New
97
-93.78K
Decreased
145
677.70K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.81%
Healthcare Providers & Services
+0.04%
Key Executives
Chairman/Director
George Walsh
President/Chief Executive Officer/Director
Kevin McNamara
Chief Financial Officer/Executive Vice President
David Williams
Executive Vice President
Spencer Lee
Executive Vice President
Nicholas Westfall
Director
Thomas Hutton
Independent Director
Joel Gemunder
Independent Director
Patrick Grace
Independent Director
Walter Krebs
Independent Director
Andrea Lindell
Independent Director
Thomas Rice
Independent Director
Donald Saunders
Independent Director
Frank Wood
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
02/19/2021
Dividend USD 0.34
02/26/2021
11/06/2020
Dividend USD 0.34
11/13/2020
08/06/2020
Dividend USD 0.34
08/14/2020
05/18/2020
Dividend USD 0.32
05/27/2020
02/21/2020
Dividend USD 0.32
02/28/2020
11/01/2019
Dividend USD 0.32
11/07/2019
08/02/2019
Dividend USD 0.32
08/09/2019
05/20/2019
Dividend USD 0.3
05/29/2019
02/22/2019
Dividend USD 0.3
03/01/2019
11/02/2018
Dividend USD 0.3
11/08/2018
08/03/2018
Dividend USD 0.3
08/10/2018
05/21/2018
Dividend USD 0.28
05/30/2018
02/16/2018
Dividend USD 0.28
02/23/2018
11/03/2017
Dividend USD 0.28
11/10/2017
08/07/2017
Dividend USD 0.28
08/10/2017
05/15/2017
Dividend USD 0.26
05/23/2017
02/17/2017
Dividend USD 0.26
02/23/2017
11/04/2016
Dividend USD 0.26
11/09/2016
08/08/2016
Dividend USD 0.26
08/11/2016
05/16/2016
Dividend USD 0.24
05/24/2016
02/19/2016
Dividend USD 0.24
02/25/2016
11/06/2015
Dividend USD 0.24
11/12/2015
08/07/2015
Dividend USD 0.24
08/13/2015
05/18/2015
Dividend USD 0.22
05/26/2015
02/20/2015
Dividend USD 0.22
02/26/2015
11/07/2014
Dividend USD 0.22
11/13/2014
08/08/2014
Dividend USD 0.22
08/14/2014
05/19/2014
Dividend USD 0.2
05/27/2014
02/21/2014
Dividend USD 0.2
02/27/2014
11/08/2013
Dividend USD 0.2
11/14/2013
08/02/2013
Dividend USD 0.2
08/08/2013
About CHE
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Webull offers kinds of Chemed Corporation stock information, including NYSE:CHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHE stock methods without spending real money on the virtual paper trading platform.